|
AU2003301195B2
(en)
|
2002-12-20 |
2010-01-07 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
TW200724548A
(en)
*
|
2005-04-25 |
2007-07-01 |
Pfizer |
Antibodies to myostatin
|
|
KR101135220B1
(ko)
*
|
2005-10-06 |
2012-04-24 |
일라이 릴리 앤드 캄파니 |
항-마이오스타틴 항체
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
US20070149458A1
(en)
*
|
2005-12-06 |
2007-06-28 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
EP4793360A2
(en)
|
2006-03-31 |
2026-08-19 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
|
HRP20130320T1
(en)
*
|
2006-09-05 |
2013-05-31 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
AU2008285289A1
(en)
|
2007-08-03 |
2009-02-12 |
Biomarin Iga Limited |
Drug combinations for the treatment of Duchenne muscular dystrophy
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
EP3127921A1
(en)
|
2007-09-26 |
2017-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method of modifying isoelectric point of antibody via amino acid substition in cdr
|
|
PE20091163A1
(es)
*
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
TW201920257A
(zh)
|
2008-04-11 |
2019-06-01 |
日商中外製藥股份有限公司 |
重複結合複數個抗原的抗原結合分子
|
|
WO2010002862A2
(en)
*
|
2008-07-01 |
2010-01-07 |
Aveo Pharmaceuticals, Inc. |
Fibroblast growth factor receptor 3 (fgfr3) binding proteins
|
|
HUP0800448A2
(en)
*
|
2008-07-21 |
2011-02-28 |
Pecsi Tudomanyegyetem |
Diagnosis of systemic diseases
|
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
|
FR2943249B1
(fr)
*
|
2009-03-18 |
2011-08-12 |
Genethon |
Utilisation de la decorine pour augmenter la masse musculaire
|
|
JO3340B1
(ar)
*
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
|
TWI654203B
(zh)
|
2010-11-30 |
2019-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
具有鈣依存性的抗原結合能力之抗體
|
|
SMT201800092T1
(it)
|
2011-11-14 |
2018-03-08 |
Regeneron Pharma |
Composizioni e metodi per aumentare la massa muscolare e la forza muscolare antagonizzando specificamente gdf8 e/o activina a
|
|
FR2982860B1
(fr)
|
2011-11-18 |
2015-07-10 |
Ass Fr Contre Les Myopathies |
Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
|
|
BR112014017814A8
(pt)
*
|
2012-01-20 |
2017-07-11 |
Genzyme Corp |
Anticorpos anti-cxcr3
|
|
CA2865158C
(en)
|
2012-02-24 |
2022-11-01 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule for promoting disappearance of antigen via fc.gamma.riib
|
|
MY177331A
(en)
*
|
2012-06-15 |
2020-09-12 |
Pfizer |
Improved antagonist antibodies against gdf-8 and uses therefor
|
|
EP4678239A3
(en)
|
2012-08-01 |
2026-04-08 |
Ikaika Therapeutics, Inc. |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
|
|
TWI855488B
(zh)
|
2012-08-24 |
2024-09-11 |
日商中外製藥股份有限公司 |
FcγRIIb特異性Fc區域變異體
|
|
JP6774164B2
(ja)
|
2012-08-24 |
2020-10-21 |
中外製薬株式会社 |
マウスFcγRII特異的Fc抗体
|
|
RS58801B1
(sr)
|
2012-09-13 |
2019-07-31 |
Bristol Myers Squibb Co |
Skafold domenski proteini na bazi fibronektina koji se vezuju za miostatin
|
|
SG11201508170TA
(en)
|
2013-04-02 |
2015-11-27 |
Chugai Pharmaceutical Co Ltd |
Fc REGION VARIANT
|
|
EP2983694B1
(en)
|
2013-04-08 |
2022-06-22 |
President and Fellows of Harvard College |
Compositions for rejuvenating skeletal muscle stem cells
|
|
HRP20201914T1
(hr)
|
2013-05-06 |
2021-01-22 |
Scholar Rock, Inc. |
Sastavi i postupci za modulaciju faktora rasta
|
|
EP3881859B1
(en)
*
|
2013-06-11 |
2024-03-06 |
President and Fellows of Harvard College |
Compositions for increasing neurogenesis and angiogenesis
|
|
TWI655207B
(zh)
|
2013-07-30 |
2019-04-01 |
再生元醫藥公司 |
抗活化素a之抗體及其用途
|
|
TW201622743A
(zh)
*
|
2014-03-19 |
2016-07-01 |
財團法人臺灣基督長老教會馬偕紀念社會事業基金會馬偕紀念醫院 |
免疫原醣肽、包含該醣肽之組合物及其用途
|
|
WO2016073853A1
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
MX2017005774A
(es)
|
2014-12-19 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
|
|
CN114773469B
(zh)
|
2015-02-05 |
2025-12-19 |
中外制药株式会社 |
包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il-8-结合抗体及其应用
|
|
WO2016168613A1
(en)
|
2015-04-15 |
2016-10-20 |
Regeneron Pharmaceuticals, Inc. |
Methods of increasing strength and functionality with gdf8 inhibitors
|
|
EA038146B1
(ru)
|
2015-09-15 |
2021-07-13 |
Сколар Рок, Инк. |
Антитела к про-/латентному миостатину и их применения
|
|
EP3394098A4
(en)
*
|
2015-12-25 |
2019-11-13 |
Chugai Seiyaku Kabushiki Kaisha |
ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE
|
|
IL293766B2
(en)
|
2016-01-06 |
2023-08-01 |
Harvard College |
Treatment with gdf11 prevents weight gain, improves glucose loading and reduces hepatosteatosis
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
TWI760396B
(zh)
|
2016-06-17 |
2022-04-11 |
日商中外製藥股份有限公司 |
抗肌抑素抗體及使用方法
|
|
CN116271014A
(zh)
|
2016-08-05 |
2023-06-23 |
中外制药株式会社 |
用于预防或治疗il-8相关疾病的组合物
|
|
HRP20230308T1
(hr)
*
|
2017-01-06 |
2023-05-12 |
Scholar Rock, Inc. |
Liječenje metaboličkih bolesti putem inhibiranja aktivacije miostatina
|
|
IL276921B2
(en)
|
2018-03-01 |
2025-12-01 |
Regeneron Pharma |
Methods for altering body composition
|
|
SMT202500283T1
(it)
|
2018-04-06 |
2025-09-12 |
Regeneron Pharma |
Un anticorpo agonista del recettore della leptina da utilizzare per aumentare la massa ossea in un soggetto affetto da disfunzione metabolica o ipoleptinemia
|
|
CN113195532B
(zh)
|
2018-12-18 |
2025-04-11 |
瑞泽恩制药公司 |
使用针对瘦素受体、gdf8和活化素a的拮抗剂增加体重和瘦肌肉质量的组合物和方法
|
|
AU2019406214A1
(en)
|
2018-12-21 |
2021-08-05 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
|
WO2020139977A1
(en)
|
2018-12-26 |
2020-07-02 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
|
JP2025532651A
(ja)
|
2022-09-21 |
2025-10-01 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
肥満、糖尿病および肝機能障害を処置する方法
|
|
CN120677175A
(zh)
|
2022-12-22 |
2025-09-19 |
供石公司 |
肌生成抑制蛋白活化的选择性和强效抑制剂
|
|
US20260199503A1
(en)
|
2025-01-10 |
2026-07-16 |
Regeneron Pharmaceuticals, Inc. |
Glp1r agonist-tethered gdf8 antibody conjugates and uses thereof
|